WPRIM Management System> DCMS> Journal of Breast Cancer> 2018> 21> 3

Volume: 21 Issue: 3

1. Deficiency of Follistatin-Like Protein 1 Accelerates the Growth of Breast Cancer Cells at Lung Metastatic Sites. Page:267—276
2. Hypoxia-Inducible Factor 1α Regulates the Transforming Growth Factor β1/SMAD Family Member 3 Pathway to Promote Breast Cancer Progression. Page:259—266
3. Hsa-miRNA-143-3p Reverses Multidrug Resistance of Triple-Negative Breast Cancer by Inhibiting the Expression of Its Target Protein Cytokine-Induced Apoptosis Inhibitor 1 In Vivo. Page:251—258
4. Patterns of Practice in Radiotherapy for Breast Cancer in Korea. Page:244—250
5. The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge. Page:233—243
6. Extraocular Muscles Involvement as the Initial Presentation in Metastatic Breast Cancer. Page:339—342
7. Gasless Robot-Assisted Nipple-Sparing Mastectomy: A Case Report. Page:334—338
8. The Novel Pathogenic Mutation c.849dupT in BRCA2 Contributes to the Nonsense-Mediated mRNA Decay of BRCA2 in Familial Breast Cancer. Page:330—333
9. Comparison of Oncoplastic Breast-Conserving Surgery and Breast-Conserving Surgery Alone: A Meta-Analysis. Page:321—329
10. Evaluating the Prediction of Breast Cancer Survival Using Lymph Node Ratio. Page:315—320
11. Comparative Study between Sentinel Lymph Node Biopsy and Axillary Dissection in Patients with One or Two Lymph Node Metastases. Page:306—314
12. Expression of DNA Damage Response Proteins and Associations with Clinicopathologic Characteristics in Chinese Familial Breast Cancer Patients with BRCA1/2 Mutations. Page:297—305
13. High RNA-binding Motif Protein 3 Expression Is Associated with Improved Clinical Outcomes in Invasive Breast Cancer. Page:288—296
14. Long Noncoding RNA Signature and Disease Outcome in Estrogen Receptor-Positive Breast Cancer Patients Treated with Tamoxifen. Page:277—287